Will Africans take COVID-19 vaccination?
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A. (2021) · Nature Medicine · doi:10.1038/s41591-020-1124-9 · Cited by 2,904
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128
COVID-19–Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis
Islam, M. S., Sarkar, T., Khan, S. H., Mostofa Kamal, A.-H., Hasan, S. M. M., Kabir, A., Yeasmin, D., Islam, M. A., Amin Chowdhury, K. I., Anwar, K. S., et al. (2020) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0812 · Cited by 1,178
Planning for a COVID-19 Vaccination Program
Schaffer DeRoo, S., Pudalov, N. J., & Fu, L. Y. (2020) · JAMA · doi:10.1001/jama.2020.8711 · Cited by 608
Fearing the disease or the vaccine: The case of COVID-19
Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., Karukivi, M., Lindfelt, M., & Antfolk, J. (2021) · Personality and Individual Differences · doi:10.1016/j.paid.2020.110590 · Cited by 491
Saied, S. M., Saied, E. M., Kabbash, I. A., & Abdo, S. A. E. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26910 · Cited by 464
Kabamba Nzaji, M., Kabamba Ngombe, L., Ngoie Mwamba, G., Banza Ndala, D. B., Mbidi Miema, J., Luhata Lungoyo, C., Lora Mwimba, B., Cikomola Mwana Bene, A., & Mukamba Musenga, E. (2020) · Pragmatic and Observational Research · doi:10.2147/por.s271096 · Cited by 411
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
British Broadcasting Corporation (BBC)
(2007) · Encyclopedia of Children, Adolescents, and the Media · doi:10.4135/9781412952606.n60 · Cited by 367
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
Wise, J. (2021) · BMJ · doi:10.1136/bmj.n699 · Cited by 325
Medical populism and the COVID-19 pandemic
Lasco, G. (2020) · Global Public Health · doi:10.1080/17441692.2020.1807581 · Cited by 313
Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
Wiysonge, C. S., Ndwandwe, D., Ryan, J., Jaca, A., Batouré, O., Anya, B.-P. M., & Cooper, S. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1893062 · Cited by 303
Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13517 · Cited by 224
Hager, E., Odetokun, I. A., Bolarinwa, O., Zainab, A., Okechukwu, O., & Al-Mustapha, A. I. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236918 · Cited by 218
Self-citationDiop, B. Z., Ngom, M., Pougué Biyong, C., & Pougué Biyong, J. N. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-002699 · Cited by 207
COVID‐19, nationalism, and the politics of crisis: A scholarly exchange
Woods, E. T., Schertzer, R., Greenfeld, L., Hughes, C., & Miller‐Idriss, C. (2020) · Nations and Nationalism · doi:10.1111/nana.12644 · Cited by 198
Iwasaki, A., & Omer, S. B. (2020) · Cell · doi:10.1016/j.cell.2020.09.040 · Cited by 184
Dinga, J. N., Sinda, L. K., & Titanji, V. P. K. (2021) · Vaccines · doi:10.3390/vaccines9020175 · Cited by 174
Chirisa, I. E., Mutambisi, T., Chivenge, M., Mabaso, E., Matamanda, A. R., & NCUBE, R. K. (2020) · GeoJournal · doi:10.1007/s10708-020-10281-6 · Cited by 154
The coronavirus disease 2019 (COVID-19) pandemic: A review and an update on cases in Africa
Anjorin, A. A. (2020) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.281612 · Cited by 141
Self-citationSchmidt, T., Cloete, A., Davids, A., Makola, L., Zondi, N., & Jantjies, M. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244420 · Cited by 137
No Jab, No Job? Ethical Issues in Mandatory COVID-19 Vaccination of Healthcare Personnel
Gur-Arie, R., Jamrozik, E., & Kingori, P. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004877 · Cited by 122
COVID-19 Vaccine Hesitancy: Shortening the Last Mile
Chevallier, C., Hacquin, A.-S., & Mercier, H. (2021) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2021.02.002 · Cited by 114
Comorbidities and the COVID‐19 pandemic dynamics in Africa
Anjorin, A. A., Abioye, A. I., Asowata, O. E., Soipe, A. I., Kazeem, M. I., Adesanya, I. O., Raji, M. A., Adesanya, M., Oke, F., Lawal, F., et al. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13504 · Cited by 87
Self-citationTanzania refuses COVID-19 vaccines
Makoni, M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00362-7 · Cited by 84
Odetokun, I. A., Akpabio, U., Alhaji, N. B., Biobaku, K. T., Oloso, N. O., Ghali-Mohammed, I., Biobaku, A. J., Adetunji, V. O., & Fasina, F. O. (2019) · Antibiotics · doi:10.3390/antibiotics8040243 · Cited by 69
Self-citationPersonal and social patterns predict influenza vaccination decision
Shaham, A., Chodick, G., Shalev, V., & Yamin, D. (2020) · BMC Public Health · doi:10.1186/s12889-020-8327-3 · Cited by 56
Abayomi, A., Osibogun, A. O., Kanma-Okafor, O. J., Idris, J., Bowale, A., Wright, O., Adebayo, B. I., Balogun, M. R., Ogboye, S., Adeseun, R., et al. (2021) · Global Health Research and Policy · doi:10.1186/s41256-021-00210-6 · Cited by 37
Aiyewumi, O., & Okeke, M. I. (2020) · Journal of Global Health · doi:10.7189/jogh.10.020375 · Cited by 32
Factors associated with the myth about 5G network during COVID-19 pandemic in sub-Saharan Africa
Ovenseri-Ogbomo, G. O., Ishaya, T., Osuagwu, U. L., Abu, E. K., Nwaeze, O., Oloruntoba, R., Ekpenyong, B. N., Mashige, K. P., Timothy, C. G., Langsi, R., et al. (2020) · Journal of Global Health Reports · doi:10.29392/001c.17606 · Cited by 31
Elnadi, H., Odetokun, I. A., Bolarinwa, O. A., Ahmed, Z. M., Okechukwu, O., & Al-Mustapha, A. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247351 · Cited by 31
Self-citationThomas, E., & Zhang, A. (2020) · Cited by 28
The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
Singh, J. A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa303 · Cited by 21
Osibogun, A., Abayomi, A., Kanma-Okafor, O. J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-70014/v1 · Cited by 6
Research works printed but not linked: 2
- World Health Organization (WHO). REPORT OF THE SAGE WORKING GROUP ON VACCINE HESITANCY. 2014.
- University of Oxford. Our World in Data 2021 [18 March, 2021]. https://ourworldindata.org/covid-vaccinations.
Cited by
COVID-19 vaccine hesitancy in Africa: a scoping review
Ackah, B. B. B., Woo, M., Stallwood, L., Fazal, Z. A., Okpani, A., Ukah, U. V., & Adu, P. A. (2022) · Global Health Research and Policy · doi:10.1186/s41256-022-00255-1 · Cited by 217
Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Harris, A. A., Smith, A. E., Lindstedt, P. A., Smith, G., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01037-2 · Cited by 143
Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study
Katoto, P. D., Parker, S., Coulson, N., Pillay, N., Cooper, S., Jaca, A., Mavundza, E. J., Houston, G. F., Groenewald, C., Essack, Z., et al. (2022) · Vaccines · doi:10.3390/vaccines10030353 · Cited by 68
“Furthermore, in a survey of 5416 Africans, 37% of participants were hesitant to accept the COVID-19 immunization once available to them (with the highest level of hesitancy observed among participants from Central Africa; 67%), and 79% were concerned about its negative effects [52].”
BackgroundSelf-citationRomate, J., Rajkumar, E., Gopi, A., Abraham, J., Rages, J., Lakshmı, R., Jesline, J., & Bhogle, S. (2022) · Vaccines · doi:10.3390/vaccines10111777 · Cited by 64
“[92] Africa General population n = 5416 Serious side effects of vaccine”
BackgroundCOVID-19 vaccine inequity in African low-income countries
Kunyenje, C. A., Chirwa, G. C., Mboma, S. M., Ng’ambi, W. F., Mnjowe, E., Nkhoma, D., Ngwira, L. G., Chawani, M. S., Chilima, B., Mitambo, C., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1087662 · Cited by 56
“Among the top 10 HICs, COVID-19 vaccine coverage was highest in Qatar (105.75”
BackgroundInfluential
Metadata
- Authors
- Anjorin, A. A., Odetokun, I. A., Abioye, A. I., Elnadi, H., Umoren, M. V., Damaris, B. F., Eyedo, J., Umar, H. I., Nyandwi, J. B., Abdalla, M. M., Tijani, S. O., Awiagah, K. S., Idowu, G. A., Fabrice, S. N. A., Maisara, A. M. O., Razouqi, Y., Mhgoob, Z. E., Parker, S., Asowata, O. E., Adesanya, I. O., Obara, M. A., Jaumdally, S., Kitema, G. F., Okuneye, T. A., Mbanzulu, K. M., Daitoni, H., Hallie, E. F., Mosbah, R., & Fasina, F. O.
- Affiliations
- Lagos State University (NG)
- University of Ilorin (NG)
- Harvard University (US)
- Université de Tours (FR)
- Cincinnati Children's Hospital Medical Center (US)
- Medizinische Hochschule Hannover (DE)
- Federal University of Technology (NG)
- Gyeongsang National University (KR)
- Minia University Hospital (EG)
- University of Lagos (NG)
- International University of Africa (SD)
- Université Sultan Moulay Slimane (MA)
- Al-Neelain University (SD)
- University of Cape Town (ZA)
- Africa Health Research Institute (ZA)
- University of St Andrews (GB)
- General Hospital Lagos, Odan (NG)
- University of Kinshasa (CD)
- University of Liberia (LR)
- Zagazig University (EG)
- Food and Agriculture Organization of the United Nations (IT)
- Corresponding author
- Fasina, Folorunso O.
- ORCID
- Anjorin, AbdulAzeez A.
- Odetokun, Ismail A.
- Abioye, Ajibola I.
- Eyedo, Joseph
- Umar, Haruna I.
- Nyandwi, Jean B.
- Abdalla, Mena M.
- Tijani, Sodiq O.
- Idowu, Gbolahan A.
- Fabrice, Sifeuh N. Achille
- Razouqi, Youssef
- Parker, Salim
- Asowata, Osaretin E.
- Jaumdally, Shameem
- Kitema, Gatera F.
- Mbanzulu, Kennedy M.
- Mosbah, Rasha
- Fasina, Folorunso O.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-12-01
- Volume
- 16
- Issue
- 12
- Pages
- e0260575
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8635331
- OpenAlex
- W3217193330
- Cited by
- 94
- References
- 35
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 9 · 2023: 47 · 2022: 26
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Edinburgh Napier Research Repository (Edinburgh Napier University) (publishedVersion, public-domain)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- St Andrews Research Repository (St Andrews Research Repository) (submittedVersion, cc-by)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- COVID-19 vaccine hesitancy, COVID-19 vaccination, vaccine willingness, vaccine side effects, perceived infection risk, vaccine literacy, vaccine affordability, mandatory vaccination, vaccine distribution, Africa
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Health Status, Humans, Male, Middle Aged, Surveys and Questionnaires, Vaccination, Knowledge, Black People, Young Adult, Health Literacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
